American College of Clinical Pharmacy
      Search      Cart
         

SCHEDULE

Adult Medicine PRN Focus Session — Building Immunity: A Guide to Managing Immune-Mediated Medications for the General Practitioner

Tuesday, November 14, 2023 from 1:15 PM to 2:45 PM CST at Lone Star Ballroom A4

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-23-124-L01-P
Activity Type: An Application-Based Activity

This educational session focuses on managing immune-mediated medications that are commonly used in the inpatient and outpatient settings, including biologic agents and intravenous immunoglobulin (IVIG). The session will highlight uncertainties that clinical pharmacists face while caring for patients receiving these medications and incorporate newer primary literature on these focus areas. Specific topics will include:

  1. Initiating and managing biologic agents, including optimal timing, starting doses, and monitoring (e.g. baseline laboratory values, adverse drug reactions (ADRs), and therapeutic drug monitoring)
  2. Managing patients who are undergoing surgery or have active infections and are prescribed biologic agents
  3. Managing patients who need to receive IVIG, including monitoring for ADRs.

The session will also identify health disparities that may impact the clinical utility of these agents and current barriers to their use. The target audience of this session is pharmacy personnel that practice in an inpatient or outpatient setting. The purpose of this session is to update adult medicine practitioners on current best practices in managing immune-mediated therapies in general medicine settings.

Faculty

Haley N. Johnson, Pharm.D., BCPSModerator: Haley N. Johnson, Pharm.D., BCPS
Title: Adult Medicine PRN Focus Session — Building Immunity: A Guide to Managing Immune-Mediated Medications for the General Practitioner
Institution: St. Louis College of Pharmacy at University of Health Sciences and Pharmacy
City/State: O Fallon, MO


Learning Objectives
1. Discuss optimal practices while initiating biologic agents.
2. Recommend appropriate monitoring parameters for biologic agents given a patient case.
3. Distinguish whether various biologic agents should be administered during acute infections or around surgical procedures.
4. Compare dosing recommendations for intravenous immunoglobulin based on indication.
5. Identify monitoring parameters for efficacy and safety of intravenous immunoglobulin therapy.

Initiating and Monitoring Biologic Agents

1:15 PM to 1:45 PM
Sheila M. Wilhelm, Pharm.D., FCCP, BCPSSpeaker: Sheila M. Wilhelm, Pharm.D., FCCP, BCPS
Title: Initiating and Monitoring Biologic Agents
Institution: Wayne State University
City/State: Troy, MI
  View Biography

Management of Biologic Agents in Perioperative Settings and Acute Infection

1:45 PM to 2:15 PM
David E. Nix, Pharm.D., FCCP, BCIDP, BCPSSpeaker: David E. Nix, Pharm.D., FCCP, BCIDP, BCPS
Title: Management of Biologic Agents in Perioperative Settings and Acute Infection
Institution: University of Arizona
City/State: Tucson, AZ
  View Biography

Administering and Monitoring Intravenous Immunoglobulin

2:15 PM to 2:45 PM
Nikitha R. Patel, Pharm.D., BCPSSpeaker: Nikitha R. Patel, Pharm.D., BCPS
Title: Administering and Monitoring Intravenous Immunoglobulin
Institution: Hospital of the University of Pennsylvania
City/State: Kendall Park, NJ
  View Biography

Cookies

This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.